DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

The DEA has once again pledged to take action to better facilitate clinical cannabis research. The U.S. Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. According to the agency's filing today in the Federal Register, the DEA "intends to promulgate regulations" to evaluate several dozen applications before it from private entities that wish to cultivate cannabis for FDA-approved research. However, this is not the first ...